original ) (raw )Arrhythmia associated with buprenorphine and methadone reported to the food and drug administration
David Kao
Addiction, 2015
View PDFchevron_right
Sessler Butrans Disproportionality analysis of cardiac arrhythmia 2016 Postgrad Medicine
Paul Coplan
View PDFchevron_right
Effects of buprenorphine on QT intervals in healthy subjects: results of 2 randomized positive- and placebo-controlled trials
Stephen Harris
Postgraduate medicine, 2017
View PDFchevron_right
Effects of Buprenorphine on Cardiac Repolarization in a Patient with Methadone-Related Torsade de Pointes
Philip Mehler
Pharmacotherapy, 2005
View PDFchevron_right
QT-Interval Effects of Methadone, Levomethadyl, and Buprenorphine in a Randomized Trial
Paul Nuzzo
Archives of Internal Medicine, 2007
View PDFchevron_right
Electrocardiogram Characteristics of Methadone and Buprenorphine Maintained Subjects
Aaron Farquharson
Journal of Addictive Diseases, 2008
View PDFchevron_right
Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose
Ingrid Berling
Clinical Toxicology, 2019
View PDFchevron_right
Buprenorphine Prescribing: To Expand or Not to Expand
Daryl Shorter
Journal of Psychiatric Practice, 2016
View PDFchevron_right
Opioid addiction agonist therapy and the QT prolongation phenomenon: state of the science and evolving research questions
Mark Haigney
Addiction, 2013
View PDFchevron_right
QTc Interval Screening in an Opioid Treatment Program
David Kao
The American Journal of Cardiology, 2013
View PDFchevron_right
Buprenorphine mortality, seizures and prescription data in the UK, 1980-2002
Adenekan Oyefeso
Human Psychopharmacology-clinical and Experimental, 2005
View PDFchevron_right
Cardiac arrhythmia and opioids: Be watchful
Abdallah Shehab
International Journal of Cardiology, 2019
View PDFchevron_right
US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system
Joseph Pergolizzi
Current Medical Research and Opinion, 2014
View PDFchevron_right
Cardiovascular disorders associated with naloxone monotherapy and in fixed-dose combination with opioids: Data from international safety surveillance
David Kao
International journal of cardiology, 2016
View PDFchevron_right
From research to the real world: Buprenorphine in the decade of the Clinical Trials Network
Gregory Brigham , Dennis McCarty , Maureen Hillhouse
Journal of Substance Abuse Treatment, 2010
View PDFchevron_right
Abuse of Buprenorphine in the United States
Herbert Kleber
Journal of Addictive Diseases, 2007
View PDFchevron_right
Trends in Reporting Methadone-Associated Cardiac Arrhythmia, 1997–2011
David Kao
Annals of Internal Medicine, 2013
View PDFchevron_right
Trends in the Use of Buprenorphine in US Emergency Departments, 2002-2017
Gail D'Onofrio
JAMA network open, 2020
View PDFchevron_right
The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment
John Renner
Journal of General Internal Medicine, 2010
View PDFchevron_right
Benefit-Risk Analysis of Buprenorphine for Pain Management
Martin Hale
Journal of Pain Research, 2021
View PDFchevron_right
QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings
Geoffrey Isbister
British journal of clinical pharmacology, 2017
View PDFchevron_right
Epidemiology of severe buprenorphine exposures reported to the U.S. Poison Centers
duc anh ngo
Drug and Alcohol Dependence, 2019
View PDFchevron_right
Methadone maintenance, QTc and torsade de pointes: Who needs an electrocardiogram and what is the prevalence of QTc prolongation?
John Strang
Drug and Alcohol Review, 2011
View PDFchevron_right
Interpretation of Urine Drug Testing Results in Patients Using Transdermal Buprenorphine Preparations for the Treatment of Chronic Noncancer Pain: Table 1
Doscientos de Pan
Pain Medicine, 2015
View PDFchevron_right
Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problem
Antony Fernandez
2013
View PDFchevron_right
Levo-alpha-acetylmethadol (LAAM) induced QTc-prolongation - results from a controlled clinical trial
Markus Gastpar
European journal of medical research, 2009
View PDFchevron_right